Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily

International Journal of Cancer

Volumn 82, Issue 1, 1999, Pages 131-136

  Zhai, Yifan ^a   Yu, Jingyi ^b   Iruela Arispe, Luisa ^c   Huang, Wei Qun ^b   Wang, Zheng ^b   Hayes, Andrew J ^b   Lu, Jiamo ^a   Jiang, Gongwei ^a   Rojas, Lorena ^a   Lippman, Marc E ^b   Ni, Jian ^a   Yu, Guo Liang ^a   Li, Lu Yuan ^b  

^a GLAXOSMITHKLINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CELL GROWTH INHIBITOR;

ANGIOGENESIS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; TARGET CELL; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 0033516714     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990702)82:1<131::AID-IJC22>3.0.CO;2-O     Document Type: Article

References (24)

1. AGGARWAL, B.B. and NATARAJAN, K., Tumor necrosis factors: developments during the last decade. Europ. Cytokine Netw., 7, 93-124 (1996).
2. BLACK, R.A. and 19 OTHERS, A metalloproteinase disintegrin that releases tumor-necrosis factor-alpha from cells. Nature (Lond.), 385, 729-733 (1997).
3. BURRUS, L.W. and OLWIN, B.B., Isolation of a receptor for acidic and basic fibroblast growth factor from embryonic chick. J. biol. Chem., 264, 18647-18653 (1989).
4. DAVIS, S., ALDRICH, T.H., JONES, P.F., ACHESON, A., COMPTON, D.L., JAIN, V., RYAN, T.E., BRUNO, J., RADZIEJEWSKI, C., MAISONPIERRE, P.C. and YANCOPOULOS, G.D., Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell, 87, 1161-1169 (1996).
5. DE VRIES, C., ESCOBEDO, J.A., UENO, H., HOUCK, K., FERRARA, N. and WILLIAMS, L.T., The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 255, 989-991 (1992).
6. FERRARA, N., WINER, J., BURTON, T., ROWLAND, A., SIEGEL, M., PHILLIPS, H.S., TERRELL, T., KELLER, G.A. and LEVINSON, A.D., Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J. clin. Invest., 91, 160-170 (1993)
7. FOLKMAN, J., Angiogenesis in cancer, vascular rheumatoid and other diseases. Nature (Med.), 1, 27-31 (1995).
8. GIMENEZ-GALLEGO, G., RODKEY, J., BENNETT, C., RIOS-CANDELORE, M., DI SALVO, J. and THOMAS, K., Brain-derived acidic fibroblast growth factor: complete amino acid sequence and homologies. Science, 230, 1385-1388 (1985).
9. GOOD, D.J., POLVERINI, P.J., RASTINEJAD, F., LE BEAU, M.M., LEMONS, R.S., FRAZIER, W.A. and BOUCK, N.P., A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. nat. Acad. Sci. (Wash.), 87, 6624-6628 (1990).
10. HIRANO, T. and 15 OTHERS, Complementary DNA for a novel human interleukin (BSF2) that induces B lymphocytes to produce immunoglobulin. Nature (Lond.), 324, 73-76 (1986).
11. IRUELA-ARISPE, M.L. and DVORAK, H.F., Angiogenesis: a dynamic balance of stimulators and inhibitors. Thrombosis Haemostasis, 78, 672-677 (1997).
12. KAYAGAKI, N., KAWASAKI, A., EBATA, T., OHMOTO, H., IKEDA, S., INOUE, S., YOSHINO, K., OKUMURA, K. and YAGITA, H., Metalloproteinase-mediated release of human Fas ligand. J. exp. Med., 182, 1777-1783 (1995).
13. LEUNG, D.W., CACHIANES, G., KUANG, W.J., GOEDDEL, D.V. and FERRARA, N., Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-1309 (1989).
14. LI, L.Y., SAFRAN, M., AVIEZER, D., BOHLEN, P., SEDDON, A.P. and YAYON, A., Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis. Biochemistry, 33, 10999-11007 (1994).
15. MAIONE, T.E., GRAY, G.S., PETRO, J., HUNT, A.J., DONNER, A.L., BAUER, S.I., CARSON, H.F. and SHARPE, R., Inhibition of angiogenesis by recombinant human platelet factor4 and related peptides. Science, 247, 77-79 (1990).
16. MAISONPIERRE, P.C. and 13 OTHERS, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, 277, 55-60 (1997).
17. MONTESANO, R. and ORCI, L., Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell. 42, 469-477 (1985).
18. O'REILLY, M.S., BOEHM, T., SHING, Y., FUKAI, N., VASIOS, G., LANE, W.S., FLYNN, E., BIRKHEAD, J.R., OLSEN, B.R. and FOLKMAN, J., Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277285 (1997).
19. O'REILLY, M.S., HOLMGREN, L., SHING, Y., CHEN, C., ROSENTHAL, R.A., MOSES, M., LANE, W.S., CAO, Y., SAGE, E.H. and FOLKMAN, J., Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79, 315-328 (1994).
20. SATO, T.N., TOZAWA, Y., DEUTSCH, U., WOLBURG-BUCHHOLZ, K., FUJIWARA, Y., GENDRON-MAGUIRE, M., GRIDLEY, T., WOLBURG, H., RISAU, W. and QIN, Y., Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature (Lond.), 376, 70-74 (1995).
21. SCHWEIGERER, L., NEUFELD, G., FRIEDMAN, J., ABRAHAM, J.A., FIDDES, J.C. and GOSPODAROWICZ, D., Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature (Lond.), 325, 257-259 (1987).
22. TERMAN, B.I., DOUGHER-VERMAZEN, M., CARRION, M.E., DIMITROV, D., ARMELLINO, D.C., GOSPODAROWICZ, D. and BOHLEN, P., Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. biophys. Res. Comm., 187, 1579-1586 (1992).
23. WENNSTROM, S., SANDSTROM, C. and CLAESSON-WELSH, L., cDNA cloning and expression of a human FGF receptor which binds acidic and basic FGF. Growth Factors, 4, 197-208 (1991).
24. ZHAI Y. and 13 OTHERS, VEGI: a novel cytokine of the TNF family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J., 13, 181-189 (1999).